ArticleDiabetology & metabolic syndrome2026

Safety and metabolic effects of HTD1801 in type 2 diabetes and MASLD: a phase Ib randomized trial.

Jiajia Mai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.